Identifying Practices to Promote Inpatient Adolescent and Influenza Vaccine Delivery

2021 ◽  
Author(s):  
Alexandra J. Mihalek ◽  
Matt Hall ◽  
Christopher J. Russell ◽  
Susan Wu
Keyword(s):  
Influenza Vaccine ◽  
Vaccine Delivery ◽  
Health Information System ◽  
Mixed Effects Modeling ◽  
Tdap Vaccine ◽  
Inpatient Settings ◽  
Generalized Linear Mixed Effects ◽  
Hospital Practices ◽  
Survey Responses ◽  
Inpatient Adolescent

OBJECTIVES Many hospitalized children are underimmunized. We assessed the association between hospital immunization practices and tetanus, diphtheria, and acellular pertussis (Tdap), meningococcal, human papillomavirus (HPV), and influenza vaccine delivery. METHODS An electronic survey regarding hospital vaccine delivery practices was distributed via the Pediatric Health Information System (PHIS) and Pediatric Research in Inpatient Settings networks to PHIS hospitals. Number of vaccines delivered and total discharges in 2018 were obtained from the PHIS database to determine hospital vaccine delivery rates; patients 11 to 18 years old (adolescent vaccines) and 6 months to 18 years old (influenza vaccine) were included. Vaccine delivery rates were risk adjusted by using generalized linear mixed-effects modeling and compared with survey responses to determine associations between the number or presence of specific practices and vaccine delivery. Adjusted HPV and meningococcal vaccine delivery rates could not be calculated because of low delivery. RESULTS Twenty-nine hospitals completed a survey (57%). 152 499 and 423 046 patient encounters were included for the adolescent and influenza vaccines, respectively. Unadjusted inpatient vaccine delivery rates varied. After adjustment, the number of practices was associated only with influenza vaccine delivery (P = .02). Visual prompts (P = .02), nurse or pharmacist ordering (P = .003), and quality improvement projects (P = .048) were associated with increased influenza vaccine delivery; nurse or pharmacist ordering had the greatest impact. No practices were associated with Tdap vaccine delivery. CONCLUSIONS The number and presence of specific hospital practices may impact influenza vaccine delivery. Further research is needed to identify strategies to augment inpatient adolescent immunization.

Financing and systems barriers to seasonal influenza vaccine delivery in community settings

Vaccine ◽  
2011 ◽  
Vol 29 (52) ◽  
pp. 9632-9639 ◽  
Author(s):  
Robert B. Penfold ◽  
Donna Rusinak ◽  
Tracy A. Lieu ◽  
Abigail Shefer ◽  
Mark Messonnier ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Seasonal Influenza ◽  
Vaccine Delivery ◽  
Community Settings ◽  
Seasonal Influenza Vaccine

Influenza Vaccine Delivery Delays from the Perspective of Primary Care Physicians

2011 ◽  
Vol 40 (6) ◽  
pp. 620-624 ◽  
Author(s):  
Sean T. O'Leary ◽  
Jennifer C. Barrow ◽  
Lon McQuillan ◽  
Matthew F. Daley ◽  
Lori A. Crane ◽  
...  
Keyword(s):  
Primary Care ◽  
Influenza Vaccine ◽  
Primary Care Physicians ◽  
Vaccine Delivery

scholarly journals Multicomponent Interventions to Enhance Influenza Vaccine Delivery to Adolescents

PEDIATRICS ◽  
2011 ◽  
Vol 128 (5) ◽  
pp. e1092-e1099 ◽  
Author(s):  
L. M. Gargano ◽  
K. Pazol ◽  
J. M. Sales ◽  
J. E. Painter ◽  
C. Morfaw ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Vaccine Delivery ◽  
Multicomponent Interventions

scholarly journals 2633. Influenza and Tdap Vaccination Coverage among Pregnant Women in the PREVAIL Cohort

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S919-S920
Author(s):  
Elizabeth P Schlaudecker ◽  
Shannon Conrey ◽  
Brady J Gelvin ◽  
Allison R Cline ◽  
Emily A DeFranco ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Pregnant Women ◽  
Sensitivity And Specificity ◽  
Vaccination Coverage ◽  
Vaccination Status ◽  
Self Report ◽  
Work Place ◽  
Maternal Recall ◽  
Tdap Vaccine ◽  
High Concordance

Abstract Background The ACIP recommends influenza and Tdap vaccination during pregnancy to reduce the risk of influenza and pertussis in the mother and her infant. We assessed influenza and Tdap vaccination coverage and associated factors among pregnant women enrolled in PREVAIL, a prospective birth cohort study in Cincinnati, OH. We assessed sensitivity and specificity of self report for both vaccines against state registry, maternal healthcare provider, and work-place records. Methods We enrolled and interviewed 265 pregnant women regarding self-reported receipt of influenza and Tdap vaccines, and obtained vaccine records from registry, electronic medical record, provider, employer, or pharmacy. We grouped subjects by documented vaccination status and analyzed demographic variables and vaccine attitudes regarding efficacy, safety, and hesitancy using unadjusted Fisher exact tests. We analyzed sensitivity and specificity of maternal recall. Results We identified documentation of influenza and Tdap vaccine receipt during pregnancy in 172/265 (64.9%) and 238/265 (89.8%) of women, respectively (Figure 1); by self report, 177/265 (66.8%) reported receiving influenza and 221/265 (83.4%) Tdap vaccine. The two most common primary reasons cited for receiving influenza vaccine were “to protect my baby” (36.7%) and “to protect myself” (26%; Figure 2). Pregnant women were more likely to get Tdap vaccine if a healthcare worker recommended it (OR 5.4). Subjects were more likely to get influenza vaccine if they believed it was effective in preventing influenza in themselves (OR 9.0) or their babies (OR 8.1). While positive recall had a high concordance (95.2% and 93.4% for influenza and Tdap, respectively), 12.5% and 32.1% of mothers incorrectly recalled not receiving an influenza or Tdap vaccine, respectively, that was documented as received in the records (Figure 3). Conclusion We found high concordance between maternal recall and verification for both influenza and Tdap vaccines. In this single-site cohort of 265 women, self report was a reliable measure of vaccination status among pregnant women. Provider communication to pregnant women regarding effectiveness of influenza and Tdap vaccinations for themselves and their infants may lead to higher maternal vaccination rates. Disclosures All authors: No reported disclosures.

scholarly journals The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings

2016 ◽  
pp. dyw022 ◽  
Author(s):  
Ivo M. Foppa ◽  
Jill M. Ferdinands ◽  
Sandra S. Chaves ◽  
Michael J. Haber ◽  
Sue B. Reynolds ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Inpatient Settings

In situ gelling nasal inserts for influenza vaccine delivery

2009 ◽  
Vol 36 (5) ◽  
pp. 581-593 ◽  
Author(s):  
Ulrike Bertram ◽  
Marie-Clotilde Bernard ◽  
Jean Haensler ◽  
Philippe Maincent ◽  
Roland Bodmeier
Keyword(s):  
Influenza Vaccine ◽  
Vaccine Delivery ◽  
In Situ Gelling
Sign in / Sign up

Export Citation Format

Share Document